PERRIGO Co plc
PRGO NYSE· Pharmaceutical Preparations
Last close · Oct 26, 2026
$15.82
KIRA · Stoqly’s AI analyst, in plain words
- PERRIGO Co plc had $4.3B of revenue in fiscal 2025, down 2.8% on the year before. Over five years, revenue changed +0.8% a year on average.
- Its operating margin was −26.4%, down 29.0 pts: of every 100 in sales, about −26 is left after running the business.
- PERRIGO Co plc lost $1.4B in fiscal 2025.
- Free cash flow was $145M in fiscal 2025, 3.4% of revenue.
- PERRIGO Co plc returned $159M to shareholders in fiscal 2025, 110% of free cash flow. The diluted share count rose 0.8%.
- PERRIGO Co plc owes $3.2B more than it holds in cash.
Market cap
$2.2B
P/E
—
Revenue
$4.3B
Net income
−$1.4B
Free cash flow
$145M
Operating margin
−26.4%
PERRIGO Co plc in 30 seconds · fiscal 2025
Are sales growing?
−2.8%
No. Sales fell 2.8% last year.
Does it make a profit?
−33.5%
No. It lost money last year.
Does profit turn into cash?
3.4%
Partly. 3.4% of sales ends up as free cash.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What PERRIGO Co plc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- PERRIGO Co plc
- CIK
- 0001585364
PERRIGO Co plc · PRGO
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| Revenue growth | 1.2% | 7.6% | 4.6% | −6.1% | −2.8% |
| Net interest income | −$125M | −$156M | −$174M | — | — |
| Gross margin | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Operating margin | 9.9% | 1.8% | 3.3% | 2.6% | −26.4% |
| Net income | −$68.9M | −$141M | −$12.7M | −$172M | −$1.4B |
| Net margin | −1.7% | −3.2% | −0.3% | −3.9% | −33.5% |
| Diluted EPS | −$0.52 | −$1.04 | −$0.09 | −$1.25 | −$10.29 |
| Cash | |||||
| Cash from operations | $156M | $307M | $406M | $363M | $239M |
| Capital expenditure | $152M | $96.4M | $102M | $118M | $93.4M |
| Free cash flow | $4.2M | $211M | $304M | $245M | $145M |
| FCF margin | 0.1% | 4.7% | 6.5% | 5.6% | 3.4% |
| Dividends paid | $130M | $142M | $150M | $153M | $159M |
| Share buybacks | $0.0M | $0.0M | — | — | — |
| Share count change | −2.6% | 0.7% | 0.6% | 1.6% | 0.8% |
| Debt and strength | |||||
| Cash and short-term investments | $1.9B | $601M | $751M | $559M | $532M |
| Debt incl. finance leases | $4.2B | $4.2B | $4.5B | $3.7B | $3.7B |
| Shareholders' equity | $5.2B | $4.8B | $4.8B | $4.3B | $2.9B |
| Net debt / EBITDA | 3.2x | 8.5x | 7.4x | 7.1x | — |
| Current ratio | 2.4x | 2.4x | 1.8x | 2.4x | 2.8x |
| Returns and quality | |||||
| Return on capital | 3.6% | 0.7% | 1.4% | 1.2% | −14.6% |
| Return on equity | −1.3% | −2.8% | −0.3% | −3.8% | −39.3% |
| Piotroski F-score | 6 | 5 | 5 | 5 | 4 |
| Altman Z'' | 2.1 | 1.2 | 1.1 | 1.1 | −0.4 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
PERRIGO Co plc · PRGO
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $15.82 a share, the company is worth $2.2B.
Source: SEC EDGAR XBRL filings (CIK 0001585364). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.